Xiaofeng Wang
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Kidney Stones and Urolithiasis Treatments 4
- Gastric Cancer Management and Outcomes 3
- Oncology 16
- Cancer Cells and Metastasis 3
- Co-authors
- Yu‐Shui Ma (11 shared papers)Da Fu (9 shared papers)Peter J. Mazzone (5 shared papers)Xiaozhen Han (3 shared papers)H. D. Petersen (1 shared paper)Qingping Yao (1 shared paper)Roy D. Altman (1 shared paper)Zixian Chen (3 shared papers)
- Journals
- Radiotherapy and Oncology (4 papers)Oncotarget (3 papers)PLoS ONE (2 papers)Technology in Cancer Research & Treatment (2 papers)CHEST Journal (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaofeng Wang
72 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 105
- Pulmonary and Respiratory Medicine 241
- Cancer Research 113
- Oncology 185
- Clinical Biochemistry 46
- Internal Medicine 16
Countries citing papers authored by Xiaofeng Wang
This map shows the geographic impact of Xiaofeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Wang more than expected).
Fields of papers citing papers by Xiaofeng Wang
This network shows the impact of papers produced by Xiaofeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Wang. The network helps show where Xiaofeng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 95 | |
| 2 | 2016 | 89 | |
| 3 | 2011 | 58 | |
| 4 | 2011 | 55 | |
| 5 | 2022 | 48 | |
| 6 | 2011 | 39 | |
| 7 | 2014 | 37 | |
| 8 | 2016 | 30 | |
| 9 | 2012 | 29 | |
| 10 | 2020 | 27 | |
| 11 | 2012 | 25 | |
| 12 | 2020 | 24 | |
| 13 | 2020 | 24 | |
| 14 | 2023 | 22 | |
| 15 | 2019 | 21 | |
| 16 | 2013 | 21 | |
| 17 | 2014 | 20 | |
| 18 | 2020 | 20 | |
| 19 | Effect of surgical castration on risk factors for arteriosclerosis of patients with prostate cancer. | 2002 | 18 |
| 20 | 2017 | 17 |
About Xiaofeng Wang
Xiaofeng Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Surgery and Pathology and Forensic Medicine, having authored 76 papers that have together received 1.0k indexed citations. Recurring topics across this work include Kidney Stones and Urolithiasis Treatments (4 papers), Ubiquitin and proteasome pathways (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Cancer Cells and Metastasis (3 papers), Gastric Cancer Management and Outcomes (3 papers), Total Knee Arthroplasty Outcomes (3 papers), Cancer-related gene regulation (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (241 citations), Cancer Research (113 citations), Oncology (185 citations), Clinical Biochemistry (46 citations) and Internal Medicine (16 citations). Xiaofeng Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yu‐Shui Ma, Da Fu, Peter J. Mazzone, Xiaozhen Han, H. D. Petersen, Qingping Yao, Roy D. Altman, Zixian Chen, Yunchao Shao and Yuan Zhao. Their work appears in journals such as Radiotherapy and Oncology, Oncotarget, PLoS ONE, Technology in Cancer Research & Treatment and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.